# Association between systemic inflammation biomarkers and outcomes in patients with aneurysmal subarachnoid hemorrhage

**Authors:** Maria Della Giovampaola, Andrea Vieno, Adeline Higuet, Irene Cavalli, Claudia Stella, Giacomo Coppalini, Alberto Diosdado, Daniel Damasceno, Lucas Freitas, Fernando Oliveira Gomes, Ana Carolina Damasceno Lacerda Fernandes, Marcos Vinicius Tavares De Magalhães, Vinicius William Costa Dumont, Fabio Silvio Taccone, Elisa Gouvêa Bogossian

PMC · DOI: 10.3389/fneur.2026.1749871 · Frontiers in Neurology · 2026-03-17

## TL;DR

This study shows that higher levels of systemic inflammation biomarkers CRP and NLr are linked to worse outcomes in patients with aneurysmal subarachnoid hemorrhage.

## Contribution

The study demonstrates that CRP and NLr are independently associated with unfavorable neurological outcomes and delayed cerebral ischemia in aSAH patients.

## Key findings

- Elevated CRP levels from days 2 to 7 after SAH were independently linked to unfavorable outcomes.
- Higher NLr values were associated with both unfavorable outcomes and delayed cerebral ischemia.
- CRP and NLr levels reinforce inflammation's role in secondary brain injury after aSAH.

## Abstract

Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating condition that is associated with cerebral and systemic inflammation. C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLr) are easily available biomarkers of systemic inflammation. Therefore, we aimed to assess the impact of elevated CRP and NLr on aSAH outcomes. This retrospective, single-center study included adult patients admitted with aSAH to the intensive care unit (ICU) from January 2007 to December 2023. We recorded serum CRP and NLr levels during the first 7 days of ICU stay. An unfavorable neurological outcome at 3 months was defined as a Glasgow Outcome Scale (GOS) score of 1–3. A total of 547 patients were included in the study; 250 (45.7%) experienced unfavorable outcomes (UOs), and 140 (25.6%) developed delayed cerebral ischemia (DCI). Patients with unfavorable outcomes had higher levels of CRP from days 2 to 7 after SAH (p = 0.001) and higher NLr (p = 0.06) than those with favorable outcomes (FOs). In a multivariate logistic regression model, the highest CRP value (OR: 1.003, 95% CI: 1.001–1.005) and the highest NLr value (OR: 1.025; 95% CI: 1.001–1.050) in the first 7 days after SAH were independently associated with the occurrence of unfavorable outcomes. The highest NLr value was also associated with the development of DCI (sHR: 1.02, 95% CI: 1.01–1.03). In conclusion, high CRP and NLr values have a significant prognostic role in aSAH patients, reinforcing the importance of inflammation as a potential mechanism of secondary brain injury.

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** brain injury (MESH:D001930), Aneurysmal subarachnoid hemorrhage (MESH:D013345), cerebral and systemic inflammation (MESH:D007249), DCI (MESH:D002545)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13035489/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13035489/full.md

## References

83 references — full list in the complete paper: https://tomesphere.com/paper/PMC13035489/full.md

---
Source: https://tomesphere.com/paper/PMC13035489